These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15498383

  • 1. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
    Sun H, Yao K, Chen Y, Zhou F.
    Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Sun H, Li BZ, Ding CN, Zhou F.
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [Abstract] [Full Text] [Related]

  • 3. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 5. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.
    Wagner HJ, Sili U, Gahn B, Vigouroux S, Huls MH, Xie W, Vignali D, Brenner MK, Heslop HE, Rooney CM.
    Cytotherapy; 2003 Apr; 5(3):231-40. PubMed ID: 12850791
    [Abstract] [Full Text] [Related]

  • 6. [Anti-nasopharyngeal carcinoma effect in vivo and in vitro of cytotoxicity T lymphocyte induced by Ad5-latent membrane protein 2A].
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Ding CL, Sun H, Li BZ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jan; 41(1):54-9. PubMed ID: 16646246
    [Abstract] [Full Text] [Related]

  • 7. [Functional effects of dendritic cells transfected with Epstein-Barr virus latent membrane protein 2A recombinant adenovirus].
    Peng G, Yau K, Xie F, Xu J, Ding C.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):171-5. PubMed ID: 12196834
    [Abstract] [Full Text] [Related]

  • 8. [Dendritic cells transfected with recombinant adenovirus Ad5F35-LMP2 induces LMP2 specific immunity mediated by cytotoxic T lymphocytes in vitro].
    Mo WN, Zhou L, Wang Z, Tang AZ, Huang GW, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):254-6. PubMed ID: 19105335
    [Abstract] [Full Text] [Related]

  • 9. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC.
    Cancer Res; 2004 Nov 01; 64(21):8022-8. PubMed ID: 15520211
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y, Huang H, Chen Z, Zong L, Xiang J.
    J Gene Med; 2003 Aug 01; 5(8):668-80. PubMed ID: 12898636
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 01; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 12. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y, Chen Z, Jia H, Wu W, Zhong S, Zhou C.
    Clin Immunol; 2006 Jun 01; 119(3):280-90. PubMed ID: 16531121
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M, Andarini S, Zaini J, Xin H, Kanehira M, Suzuki T, Fukuhara T, Mizuguchi H, Hayakawa T, Saijo Y, Nukiwa T, Kikuchi T.
    Eur J Immunol; 2006 Apr 01; 36(4):1019-27. PubMed ID: 16525992
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y, Weng X, Liu X, Zhu H, Chen Z, Jiang B, Chen H.
    Cancer Lett; 2010 Jul 28; 293(2):254-62. PubMed ID: 20149524
    [Abstract] [Full Text] [Related]

  • 15. [Anti-tumor immune response of dendritic cells transfected with wild-type p53 gene].
    Liu HJ, Xin JB, Li ZY, Xiong XZ, Tao XN, Hu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec 28; 31(12):902-7. PubMed ID: 19134406
    [Abstract] [Full Text] [Related]

  • 16. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.
    Ito Y, Kondo E, Demachi-Okamura A, Akatsuka Y, Tsujimura K, Tanimoto M, Morishima Y, Takahashi T, Kuzushima K.
    J Virol; 2006 Jan 28; 80(2):883-90. PubMed ID: 16378990
    [Abstract] [Full Text] [Related]

  • 17. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 28; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, Kang WK, Hong YK, Kim TG.
    Vaccine; 2006 Apr 05; 24(15):2860-8. PubMed ID: 16443309
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
    Yang JY, Cao DY, Liu WC, Zhang HM, Teng ZH, Ren J.
    Cell Immunol; 2006 Mar 05; 240(1):14-21. PubMed ID: 16875681
    [Abstract] [Full Text] [Related]

  • 20. In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus.
    Pan Y, Zhang J, Zhou L, Zuo J, Zeng Y.
    Biochem Biophys Res Commun; 2006 Sep 01; 347(3):551-7. PubMed ID: 16842756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.